Catalyst Wire Dossier Catalyst Wire Dossier

Risedronate delayed-release 35 mg

risedronate · Warner Chilcott
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Risedronate delayed-release 35 mg, covering 2011-06-21 to 2011-06-21. Get the full timeline:

Most recent: Clinical Trial Update: A Study of a 35 mg Delayed Release Formulation of Risedronate for Osteoporosis [Phase 3]

See pricing